Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used.
about
Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90.BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy.The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells.Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.Chemosensitization of prostate cancer by modulating Bcl-2 family proteins.Use of GC/MS to identify chemical constituents and cytotoxic activity of the leaves of Phoradendron mucronatum and Phoradendron microphyllum (Viscaceae).ROS-mediated EB1 phosphorylation through Akt/GSK3β pathway: implication in cancer cell response to microtubule-targeting agents.Probenecid is a chemosensitizer in cancer cell lines.Bcl-2 down modulation in WEHI-3B/CTRES cells resistant to Cholera Toxin (CT)-induced apoptosis.Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.The search for optimal cutoff points for apoptosis and proliferation rate in prognostification of early stage breast cancer patients treated with anthracyclines in adjuvant settings.Caspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: a meta-analysis of 3091 cases.
P2860
Q33644391-2E7A7CF1-02CB-4249-8AEC-FAD50ADF7E72Q34491903-C4B220AC-9086-45B4-A7FA-1D4A93635135Q36146466-2F91326E-4EC5-4483-9532-97BCB79641C2Q36567569-9B58ACA4-1188-42B1-889D-2A2CE9E6ED5AQ37713757-EEDEEC2D-D702-4676-8C02-52DBDDC02F45Q38896275-DB19DB85-13C4-48F0-91D1-91F8E609CC96Q38984621-076A23F4-E3B4-4D64-A8D8-066902EC4BD7Q39485986-B49E9B6E-8D78-4E61-98EA-11771962ED2EQ40304019-1882FC15-6158-476C-9ABA-0EC427E8BF63Q40576657-0B7230CE-3FE4-4AE3-9DC7-441839B29EB0Q41034390-AFC2D8C6-52F6-4E23-A73F-D6122B1B54DCQ50319061-90AB728F-7B8C-4272-823B-1D845F3A64D9
P2860
Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Bcl-2 has differing effects on ...... the antineoplastic drug used.
@en
Bcl-2 has differing effects on ...... the antineoplastic drug used.
@nl
type
label
Bcl-2 has differing effects on ...... the antineoplastic drug used.
@en
Bcl-2 has differing effects on ...... the antineoplastic drug used.
@nl
prefLabel
Bcl-2 has differing effects on ...... the antineoplastic drug used.
@en
Bcl-2 has differing effects on ...... the antineoplastic drug used.
@nl
P2093
P50
P1476
Bcl-2 has differing effects on ...... n the antineoplastic drug used
@en
P2093
P304
P356
10.1016/S0959-8049(02)00391-X
P577
2002-12-01T00:00:00Z